FDA ap­proves decade-old Pfiz­er drug for rare child­hood leukemia

A Pfiz­er leukemia drug that has been ap­proved in adults for more than a decade will soon be avail­able for kids 1 year and old­er.

Bo­sulif, al­so known as bo­su­tinib, was ap­proved by the FDA on Tues­day for chil­dren with a rare type of bone mar­row can­cer called chron­ic phase (CP) Philadel­phia chro­mo­some-pos­i­tive (Ph+) chron­ic myel­oge­nous leukemia (CML). Most pa­tients with CML have an ab­nor­mal chro­mo­some in their blood cells called the Philadel­phia chro­mo­some, named af­ter its dis­cov­ery by re­searchers in the Penn­syl­va­nia city.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER